Organon Standard Deviation
| OGN Stock | | | USD 13.32 -0.09 -0.67% |
The Standard Deviation is a measure of how spread out the prices or returns of an asset are on average. It is the most widely used risk indicator in the field of investing and finance. Standard Deviation is commonly used to measure confidence in statistical conclusions regarding certain equity instruments or portfolios of equities. Below is Organon's current Standard Deviation with peer comparisons and related risk metrics.
Current Standard Deviation Value
Organon registers a Standard Deviation of 6.66, reflecting elevated price variability. This places Organon toward the higher end of the volatility range for Pharmaceuticals.
Standard Deviation | = | SQRT(V) |
| = | 6.66 | |
Standard Deviation Peers Comparison
Among sector peers, Organon's Standard Deviation of 6.66 is above the 3.23 group average. The range runs from 1.43 (Select Medical Holdings) to 5.04 (Phibro Animal Health). Organon has exhibited greater price dispersion than the peer average over the measured period.
Standard Deviation Relative To Other Indicators
The chart below plots Standard Deviation against Maximum Drawdown for Organon and its peers. Each point represents one equity — position along the horizontal axis shows Standard Deviation while the vertical axis shows Maximum Drawdown. Equities that cluster in different quadrants carry distinct risk-return profiles. Use the dropdowns to swap in other indicators for either axis.
Organon shows nearly
5.06 of Maximum Drawdown per unit of Standard Deviation (
6.66 versus
33.69 ). This indicates Maximum Drawdown substantially exceeds Standard Deviation for Organon.
Methodology, Assumptions & Data Sources
Organon's Standard Deviation currently stands at 6.66. This Standard Deviation reading for Organon results from applying the indicator's calculation rules to price and volume data over the selected window. Inputs are drawn from end-of-day closing prices reported by supported exchanges, adjusted for splits and dividends where applicable. Organon operates in the health care sector, which may exhibit distinct volatility and momentum characteristics relative to the broader market. Values are specific to the selected time horizon and may differ across measurement periods. This indicator does not constitute investment advice.
Other Technical Indicators